Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_assertion type Assertion NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_head.
- NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_assertion description "[Our findings suggest that LRRC42 overexpression as well as its interaction with LRRC42-GATAD2B might play essential roles in lung carcinogenesis, and be a promising molecular target for lung cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_provenance.
- NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_assertion evidence source_evidence_literature NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_provenance.
- NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_assertion SIO_000772 24806090 NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_provenance.
- NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_assertion wasDerivedFrom befree-20150227 NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_provenance.
- NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_assertion wasGeneratedBy ECO_0000203 NP930395.RA6P63A3rtxWOGGyEagONR8pdzGDSOcbrHmOx-qKY8vEs130_provenance.